13.06.2013 Views

Infezione da EBV Mononucleosi infettiva - Il diario di Fable

Infezione da EBV Mononucleosi infettiva - Il diario di Fable

Infezione da EBV Mononucleosi infettiva - Il diario di Fable

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Antibo<strong>di</strong>es to Epstein-Barr Virus<br />

Antibody specificity Time of Appearance % positives Persistence Comments<br />

in IM<br />

Viral capsid antigens<br />

IgM VCA At clinical presentation 100 4-8 wk Highly sensitive and specific,<br />

major <strong>di</strong>agnostic utility<br />

IgG VCA At clinical presentation 100 Lifelong High titer at presentation and<br />

lifelong persistance make IgG<br />

VCA more useful as epidemiologic<br />

tool than in <strong>di</strong>agnosis of cases<br />

Early antigens (EA)<br />

Anti-D peaks at 3-4 wk after onset 70 3-6 mo Correlated with severe <strong>di</strong>seas; also<br />

seen in nasopharyngeal carcinoma<br />

Anti-R 2 wk to several months after onset Low 2mo to>3yr Occasionally seen with unusually<br />

severe or protracted illness; also<br />

seen in African Burkitt’slymphoma<br />

Epstein-Barr 3-4 wk after onset 100 Lifelong Late appearance helpful in<br />

nuclear antigen (EBNA) <strong>di</strong>agnosis of heterophile-negative<br />

cases<br />

Soluble complement- 3-4 wk after onset 100 Lifelong Late appearance helpful in<br />

fixing antigens (anti-S) <strong>di</strong>agnosis of<br />

heterophile-negative<br />

cases

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!